These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17629366)
1. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. Soler E; Parez N; Passet B; Dubuquoy C; Riffault S; Pillot M; Houdebine LM; Schwartz-Cornil I Vaccine; 2007 Aug; 25(34):6373-80. PubMed ID: 17629366 [TBL] [Abstract][Full Text] [Related]
2. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697 [TBL] [Abstract][Full Text] [Related]
3. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532 [TBL] [Abstract][Full Text] [Related]
4. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice. McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Dennehy M; Bourn W; Steele D; Williamson AL Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069 [TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936 [TBL] [Abstract][Full Text] [Related]
7. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice. Shuttleworth G; Eckery DC; Awram P Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236 [TBL] [Abstract][Full Text] [Related]
8. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection. Liu X; Yang T; Sun QM; Sun MS Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394 [TBL] [Abstract][Full Text] [Related]
9. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033 [TBL] [Abstract][Full Text] [Related]
11. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice. Agnello D; Hervé CA; Lavaux A; Darniot M; Guillon P; Charpilienne A; Pothier P J Virol; 2006 Apr; 80(8):3823-32. PubMed ID: 16571799 [TBL] [Abstract][Full Text] [Related]